序号 |
标题 |
次数 |
作者 |
发布时间 |
75826 |
NH2-Sar10-COOH,ADC定制 |
74 |
wyh |
2024-12-19 |
75827 |
cas:1415328-95-8,NHPI-PEG4-C2-NHS ester |
96 |
zyl |
2024-12-19 |
75828 |
Gd-GlyMe-DOTA-全氟辛基甘露糖缀合物(Gadofluorine M) |
129 |
h |
2024-12-19 |
75829 |
MC-Val-Cit-PAB-PNP(CAS号:159857-81-5) |
115 |
WYQ |
2024-12-19 |
75830 |
Mal-Gly-Gly-L-Phe-N-[(carboxymethoxy)methyl]Glycinamide,ADC定制 |
85 |
wyh |
2024-12-19 |
75831 |
L-RNA寡核苷酸的功能化DOTA |
99 |
h |
2024-12-19 |
75832 |
MA-PEG4-Glu(t-Bu)-Val-Cit-PAB-PNP,在药物递送系统中具有广泛应用潜力 |
78 |
WYQ |
2024-12-19 |
75833 |
cas:1415800-42-8,perfluorophenyl 1-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-3,6,9,12-tetraoxapentadecan-15-oate |
68 |
zyl |
2024-12-19 |
75834 |
羟基磺基琥珀酰亚胺DOTA(DOTA-OSSu) |
114 |
h |
2024-12-19 |
75835 |
Mal-PEG1-Val-Cit-OH,生物化学和药物研发领域有潜在应用 |
85 |
WYQ |
2024-12-19 |
75836 |
cas:1193111-39-5,1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid |
79 |
zyl |
2024-12-19 |
75837 |
DOTA-GGG-BN(7-14) |
81 |
h |
2024-12-19 |
75838 |
CAS: 108-30-5,Dihydrofuran-2,5-dione(丁二酸酐) |
109 |
WYQ |
2024-12-19 |
75839 |
cas:1884578-00-0 Boc-Val-Ala-PAB-PNP |
92 |
zyl |
2024-12-19 |
75840 |
DOTA-L22-异硫氰酸荧光素-依沙酸 |
80 |
h |
2024-12-19 |
75841 |
cas:2768446-73-5 DBCO-Val-Cit-PAB-MMAE |
74 |
zyl |
2024-12-19 |
75842 |
Boc-PEG4-Val-Ala-PAB,ADC定制 |
84 |
wyh |
2024-12-19 |
75843 |
CAS: 2504147-59-3,MC (C5)-Val-Cit |
69 |
WYQ |
2024-12-19 |
75844 |
CAS: 159857-80-4,MC-Val-Cit-PAB-OH |
88 |
WYQ |
2024-12-19 |
75845 |
cas:2055024-65-0 Azido-PEG3-Val-Cit-PAB-OH |
84 |
zyl |
2024-12-19 |
75846 |
Mal-Amide-PEG4-Val-Cit-PAB-OH,ADC定制 |
66 |
wyh |
2024-12-19 |
75847 |
CAS 2249935-92-8:Mal-PEG1-Val-Cit-PAB-PNP |
92 |
WYQ |
2024-12-19 |
75848 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
91 |
zyl |
2024-12-19 |
75849 |
Alkyne-Val-Cit-PAB-OH,ADC定制 |
130 |
wyh |
2024-12-19 |
75850 |
CAS 2395887-69-9:Mal-PEG2-Val-Cit-PAB-PNP |
82 |
WYQ |
2024-12-19 |
75851 |
CAS 1438853-35-0:Mal-PEG3-Val-Cit-PAB-PNP |
66 |
WYQ |
2024-12-19 |
75852 |
N-(Methyltetrazine-PEG4)-amido-PEG8-3,4-dithiophenolmaleimide |
101 |
zyl |
2024-12-19 |
75853 |
MC-beta-Ala-alpha-GlcA-MMAE,ADC定制 |
109 |
wyh |
2024-12-19 |
75854 |
Mal-PEG2-Val-Cit-PAB-OH(CAS: 2055041-38-6) |
74 |
WYQ |
2024-12-19 |
75855 |
cas:2100306-78-1,t-Butyl 3-(hydroxypropoxyl)-propanoate |
87 |
zyl |
2024-12-19 |
75856 |
NHS ester-PEG4-VC-PAB-Daunorubicin,ADC定制 |
74 |
wyh |
2024-12-19 |
75857 |
Mal-PEG3-Val-Cit-PAB-OH(CAS: 2727965-49-1) |
103 |
WYQ |
2024-12-19 |
75858 |
cas:1539292-60-8,tert-butyl 3-(4-(2-cyanoethynyl)phenylcarbamoyl)propylcarbamate |
64 |
zyl |
2024-12-19 |
75859 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
68 |
wyh |
2024-12-19 |
75860 |
cas:34450-18-5,Alkynyl Stearic Acid,17-十八炔酸 |
120 |
zyl |
2024-12-19 |
75861 |
Mal-PEG4-Val-Cit-PAB-OH(CAS: 2055041-39-7) |
112 |
WYQ |
2024-12-19 |
75862 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
71 |
wyh |
2024-12-19 |
75863 |
cas:120550-35-8,Biotin-PFP ester,五氟苯酚生物素酯 |
223 |
zyl |
2024-12-19 |
75864 |
MTS-ADO3A 三酸DOTA衍生物 |
100 |
h |
2024-12-19 |
75865 |
NHS-PEG2-NH-Xanomeline,ADC定制 |
86 |
wyh |
2024-12-19 |
75866 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
119 |
h |
2024-12-19 |
75867 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
78 |
h |
2024-12-19 |
75868 |
cas:2123482-78-8,TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
68 |
zyl |
2024-12-19 |
75869 |
GG-Tesirine,ADC定制 |
112 |
wyh |
2024-12-19 |
75870 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
148 |
h |
2024-12-19 |